METTL3 and non-small cell lung carcinoma: CircVMP1 targets the miR-524-5p-METTL3/SOX2 axis to promote cisplatin resistance in tumor cells, transmitting malignant features and cisplatin resistance to cisplatin-sensitive non-small cell lung cancer (NSCLC) (Xie et al., 2022).